EverSource Wealth Advisors’s CureVac CVAC Stock Holding History

EverSource Wealth Advisors’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,095	Closed	-$4.95K	–	4417
2025 Q4	$4.95K	Hold	1,095	–	–	﹤0.01%	3124
2025 Q3	$5.9K	Hold	1,095	–	–	﹤0.01%	3085
2025 Q2	$5.95K	Buy	1,095 +429	+64%	+$1.7K	﹤0.01%	3083
2025 Q1	$1.84K	Buy	+666	New	+$2.32K	﹤0.01%	2959
2024 Q4	–	Sell	-181	Closed	-$532	–	3765
2024 Q3	$532	Buy	181 +164	+965%	+$540	﹤0.01%	2865
2024 Q2	$64	Buy	+17	New	+$56	﹤0.01%	3018
2024 Q1	–	Sell	-90	Closed	-$379	–	2917
2023 Q4	$379	Buy	90 +34	+61%	+$184	﹤0.01%	2561
2023 Q3	$382	Buy	+56	New	+$495	﹤0.01%	2423

EverSource Wealth Advisors's CVAC Position: Q1 2026 in Review

EverSource Wealth Advisors sold out of CureVac (CVAC) in Q1 2026, closing a stake of 1,095 shares — an estimated $4.95K sold.

EverSource Wealth Advisors first reported a position in CVAC in Q3 2023 and held it in 8 quarters. The position peaked at $5.95K in Q2 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

EverSource Wealth Advisors reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
EverSource Wealth Advisors sold 1,095 CureVac shares in Q1 2026, an estimated $4.95K.
EverSource Wealth Advisors first reported a position in CureVac in Q3 2023 and held it in 8 quarters.
EverSource Wealth Advisors's CureVac position peaked at $5.95K in Q2 2025.
0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.